Oblenio Bio

Blood & Organ Banks · Massachusetts, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

4 Maguire Rd, Lexington, Massachusetts, ...

Revenue

<$5 Million

Industry

Blood & Organ Banks Business Services Healthcare Services Research & Development

About Oblenio Bio

Oblenio Bio is a biotechnology company developing next-generation immunotherapies for severe autoimmune diseases. The company is advancing tri-specific T-cell engager therapies designed to selectively deplete disease-causing immune cells and achieve long-term immune reset. Its research focuses on addressing the underlying mechanisms of autoimmune disorders to develop transformative treatments with the potential for durable, drug-free remission.Explore more
Oblenio Bio's Social MediaSIC Code 28,283NAICS Code 32,325Show more

Oblenio Bio Org Chart

PhoneEmail
IC
United States flag for contact location.

Vice President, Controller

PhoneEmail
Scott Plevy, Chief Scientific Officer at Oblenio Bio
United States flag for contact location.

Chief Scientific Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
RL
United States flag for contact location.

Senior VP, Corporate Development & Strategy

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
Illustration of an envelope

Top Blood & Organ Banks Companies

Frequently Asked Questions Regarding Oblenio Bio

What is Oblenio Bio's official website?
Oblenio Bio's official website is www.obleniobio.com
What is Oblenio Bio's Revenue?
Oblenio Bio's revenue is <$5 Million
What is Oblenio Bio's SIC code?
Oblenio Bio's SIC: 28,283
What is Oblenio Bio's NAICS code?
Oblenio Bio's NAICS: 32,325
How many employees does Oblenio Bio have?
Oblenio Bio has 1-10 employees
What industry does Oblenio Bio belong to?
Oblenio Bio is in the industry of: Blood & Organ Banks, Business Services, Healthcare Services
What does Oblenio Bio do?

Oblenio Bio is a biotechnology company developing next-generation immunotherapies for severe autoimmune diseases. The company is advancing tri-specific T-cell engager therapies designed to selectively deplete disease-causing immune cells and achieve long-term immune reset. Its research focuses on addressing the underlying mechanisms of autoimmune d... isorders to develop transformative treatments with the potential for durable, drug-free remission.Read More

What are Oblenio Bio social media links?
Oblenio Bio Linkedin page
Who invested in Oblenio Bio?
Oblenio Bio has 4 investors including Deep Track Capital, Pfizer, GV and Aditum Bio.
Is Oblenio Bio a public company?
Oblenio Bio is private company therefore does not currently have an official ticker symbol
See more information about Oblenio Bio

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.